Cargando…

Evaluación de la satisfacción de los pacientes crónicos con los dispositivos de telemedicina y con el resultado de la atención recibida. Programa ValCrònic

OBJECTIVE: To evaluate patient satisfaction with the ValCrònic program, telemedicine devices, and the results of the care received after a 2-year follow-up. DESIGN: Observational, descriptive study based on telephone surveys. SETTING: The autonomous community of Valencia (Spain). PARTICIPANTS: Parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mira-Solves, José J., Orozco-Beltrán, Domingo, Sánchez-Molla, Manuel, Sánchez García, Julio Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171431/
https://www.ncbi.nlm.nih.gov/pubmed/25262307
http://dx.doi.org/10.1016/S0212-6567(14)70061-7
Descripción
Sumario:OBJECTIVE: To evaluate patient satisfaction with the ValCrònic program, telemedicine devices, and the results of the care received after a 2-year follow-up. DESIGN: Observational, descriptive study based on telephone surveys. SETTING: The autonomous community of Valencia (Spain). PARTICIPANTS: Participants consisted of 410 patients with one or more of the following diseases: hypertension, heart failure, diabetes, or chronic obstructive pulmonary disease. A total of 585 patients were included, of whom 104 left the program (18 due to death) and 71 refused to participate. METHODS: We designed and validated a specific scale. Floor and ceiling effects were considered. Internal consistency was analyzed using Cronbach's alpha. RESULTS: Responses were obtained from 322 patients (response rate, 78.5%). Of these, 118 (36.6%) were women. In 48 patients (14.9%), the person responding was a caregiver. Cronbach's alpha was 0.7. For 278 patients (86.3%), the ValCrònic program helped them to understand their disease better, 270 (83.9%) reported that it helped them use their medication more safely, and 283 (87.9%) reported they had better knowledge of their disease. For 288 (89.4%), the devices were easy to manage at home. Only 12 patients (3.7%) found that the devices involved a heavy workload that was difficult to incorporate into their daily lives. CONCLUSIONS: The ValCrònic program promotes self-care among patients.